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Edited by Vladimir SkulachevAbstract Fatty acids induced an increase in reactive oxygen
species (ROS) and enhanced NF-jB activation in L6 myotubes
diﬀerentiated in culture. Palmitate proved more eﬀective than
oleate in eliciting these eﬀects. The induction of uncoupling
protein-3 (UCP3) at levels similar to those occurring in vivo,
attained through the use of an adenoviral vector, led to a reduc-
tion of mitochondrial membrane potential in L6 myotubes. How-
ever, the capacity of palmitate to increase ROS was not reduced
but, quite the opposite, it was moderately enhanced due to the
presence of UCP3. The presence of UCP3 in mitochondria did
not modify the expression of genes encoding ROS-related en-
zymes, either in basal conditions or in the presence of palmitate.
However, in the presence of UCP3, UCP2 mRNA expression
was down-regulated in response to palmitate. We conclude that
UCP3 does not act as a protective agent against palmitate-
dependent induction of ROS production in diﬀerentiated skeletal
muscle cells.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Uncoupling protein-3 is a member of the uncoupling protein
(UCP) family expressed preferentially in skeletal muscle [1].
Like UCP1, the founder member of the family, UCP3 can
uncouple respiratory chain from oxidative phosphorylation
[2]. Over-expression of UCP3 in several cell lines and tissue
systems reduces mitochondrial membrane potential, whereasAbbreviations: ROS, reactive oxygen species; UCP, uncoupling pro-
tein; BSA, bovine serum albumin; DMEM, Dulbecco’s modiﬁed
Eagle’s medium; FBS, fetal bovine serum; EMSA, electrophoretic
mobility shift assay; GPX-1, glutathione peroxidase-1; SOD, super-
oxide dismutase
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doi:10.1016/j.febslet.2007.01.085mitochondria from UCP3 gene-null mice exhibit high mito-
chondrial membrane potential [3–5]. Increasing evidence indi-
cates that fatty acids directly activate the proton conductance
of UCP3, while GDP’s capacity to inhibit it has been demon-
strated in reconstituted systems or in permeabilized cells
expressing UCP3, but not in heterologous yeast expression sys-
tems [6–9]. From a physiological point of view, however, it
appears that UCP3 is not particularly involved in mediating
cold-induced or diet-induced thermogenesis [4,5] and its
involvement in heat production has only been demonstrated
in relation to drug-induced hyperthermia [10].
The transcription of the UCP3 gene is extremely sensitive to
the availability of free fatty acids to skeletal muscle. Thus, in
multiple physiological or pathological situations (fasting,
high-fat diets, lactation, exercise, etc.), UCP3 mRNA and pro-
tein levels are dramatically modulated depending on changes
in circulating free fatty acid levels, whatever their source (diet
or lipolysis in white fat depots) [11,12]. Although these obser-
vations did not provide any direct information on the physio-
logical role of UCP3, they suggested that UCP3 function
might be related to fatty acid metabolism in skeletal muscle.
Several hypothesis have been proposed in relation to the phys-
iological role of UCP3 in relation to fatty acids. UCP3 has
been proposed to favor fatty acid oxidation in cells and, for
instance, an increase in fatty acid versus glucose oxidation
has been reported in skeletal muscle cells expressing high levels
of UCP3 [13,14]. Indeed, some authors have hypothesized that
UCP3 could favour the export of fatty acids from mitochon-
dria when the former’s oxidation capacity is exceeded by fatty
acid availability [15,16]. Another hypothesis propose that
UCP3 may have protective eﬀects by translocating fatty acid
peroxides from the inner to the outer membrane leaﬂet in
mitochondria, and this mechanism would also account for
uncoupling activity [17,18]. On the other hand, data on the
biochemical behaviour of UCP3 has led to the proposal that
its uncoupling activity leads to a reduction in reactive oxygen
species (ROS) production by mitochondria, similarly to what
has been proposed for UCP2 [19–21]. Thus, UCP3-null mice
exhibited enhanced ROS production in skeletal muscle mito-
chondria and accumulation of products resulting from oxida-
tive stress in this tissue [5,22]. These ﬁndings would be
consistent with prior bioenergetic studies in mitochondria that
led to the conclusion that ‘‘mild-uncoupling’’ is associated with
protection against ROS production [23]. Moreover, ROS orblished by Elsevier B.V. All rights reserved.
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[19,24]. However, other studies have questioned this role for
UCP3 and it has been highlighted that evidence for a signiﬁ-
cant physiological role of UCP2 or UCP3 in protection against
ROS is still circumstantial [25].
A likely hypothesis for the role of UCP3 in skeletal muscle
may be that UCP3 gene expression is induced as a protective
mechanism, when high free fatty acids are available, without
excess ROS production [26]. Such a hypothesis would link
events such as fatty acid-dependent regulation of UCP3 gene
to the control of ROS production. However, direct evidence
for this scenario is lacking. First, there is no experimental data
regarding the eﬀects of fatty acids on ROS production specif-
ically in skeletal muscle cells and the eﬀects of fatty acid on cel-
lular ROS are known to be highly variable, ranging from
induction to inhibition depending on the cell type [27–30]. Sec-
ond, it remains unknown whether UCP3 levels inﬂuence ROS
production in skeletal muscle cells speciﬁcally in response to
high fatty acid levels.
In the present study we show that fatty acids induce ROS
production and NF-jB activity, a sensor of cellular oxidative
stress and mediator of several cellular ROS eﬀects, in diﬀeren-
tiated L6 muscle cells. UCP3, while lowering mitochondrial
membrane potential, does not act as a protective agent against
these overall eﬀects.2. Materials and methods
L6 (L6-E9 cells, kindly supplied by Dr. A. Zorzano) were grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing 10% fetal
bovine serum (FBS). To induce diﬀerentiation, L6 cells at 80% conﬂu-
ence were changed to DMEM containing 2% FBS. Subsequently, L6
were maintained for 5 days under these culture conditions to acquire
myotube morphology. After 3 days of diﬀerentiation, L6 myotubes
were infected with adenoviral vectors at a multiplicity of infection rate
of 200. This treatment led to a transduction eﬃciency of approximately
90%. Analyses (ROS levels, NF-jB activation, real-time PCR, and
western blot) were performed 2 days after transduction. Recombinant
adenoviruses expressing the human UCP3 cDNA (AdCMV-UCP3) or
Escherichia coli b-galactosidase (AdCMV-LacZ), under the control of
the cytomegalovirus promoter were obtained and handled as previ-
ously reported [13].
Oleate and palmitate salts were prepared immediately before use by
dissolving the fatty acid in deionized water containing 1.2 equiv. of
NaOH at 70 and 95 C, respectively, until an optically clear dispersion
was obtained. Fatty acid salt solution was immediately added to
DMEM medium containing fatty acid free bovine serum albumin
(BSA) (Sigma) with continuous agitation to avoid precipitation. Fol-
lowing 1 h of conjugation at 37 C, this medium was added to the cells.
The fatty acid:BSA molar ratio was 5:1.
The probe 6-carboxy-20,7 0-dichlorodihydroﬂuorescein diacetate,
diacetoxymethyl-ester (H2-DCFDA; DCF, 2
0,7 0-dichlorodihydroﬂuo-
rescein, Molecular Probes, USA) was used to estimate the generation
of intracellular ROS as previously reported [31]. DWm was estimated
by using the JC-1 probe (Molecular Probes, USA) in accordance with
supplier’s instructions. After being transduced with the adenoviral vec-
tors, L6 myotubes were rinsed in serum-free medium and incubated
with 5 lM of JC-1 at 37 C for 15 min in the dark. After rinsing the
cells with serum-free culture medium, the cell plates were analyzed with
a confocal microscope. The ratio of the reading at 590 nm to that at
527 nm (590:527 ratios) was considered as the relative DWm value.
The chemical uncoupler CCCP (5 lM, 40 min) was used as a positive
control for DWm decrease. Caspase-3 activity was measured using the
ﬂuorimetric CaspACE Assay System (Promega) whereas caspase-9
activation, was determined by immunoblotting of proteins from
homogenates probed with a rabbit polyclonal antibody speciﬁc for
the cleaved, active form, of caspase-9 (Cell Signaling technology
9505, 1:1000), as reported elsewhere [9].Assessment of palmitate oxidation was performed as already
described [13]. Brieﬂy, following adenoviral vector infection, myotubes
were starved in glucose-deprived DMEM for 1 h before the assay. Cells
were incubated at 37 C in DMEM containing 0.5 mM palmitate (9,10-
[3H]palmitate, 12 lCi/ml), BSA (fatty acid to BSA ratio of 5:1) and
3 mM glucose for 3 h. Palmitate oxidation was assessed by measuring
3H2O produced in the incubation medium.
Mitochondria were isolated from L6 myotubes as already reported
[9]. Mitochondria-enriched extracts were also prepared from gastroc-
nemius muscles obtained from Wistar rats fed a high-fat diet (80%
fat/20%protein) for three months, as previously described [9]. Protein
concentrations of subcellular fractions were measured using the BCA
Protein Assay Kit (Pierce). Mitochondria samples were separated by
SDS–PAGE on 12.8% and transferred to polyvinylidene ﬂuoride mem-
branes (Immobilon-P, Millipore). These were incubated with antibod-
ies against UCP3 (Chemicon AB3046 (1:1000)), voltage-dependent
anion carrier (VDAC) (Calbiochem Anti-Porin 31HL (1:1000)). Anti-
body binding was detected with a horseradish peroxidase-coupled anti-
mouse (Bio-Rad 170-6516 (1:3000)) or anti-rabbit (Santa Cruz sc-2004
(1:3000)) secondary antibody, as well as an enhanced chemilumines-
cence (ECL) detection kit (Amersham).
Isolation of nuclear protein extracts from L6 myotubes was per-
formed as previously reported [32] and used in electrophoretic mobility
shift assays (EMSA). A double-stranded oligonucleotide correspond-
ing to a consensus NF-jB DNA binding site (5 0-TCT AGA GTT
GAG GGG ACT TTC CCA G-30, obtained from Roche Applied Sci-
ence) was end-labeled using [a-32P] dCTP and Klenow enzyme. NF-
jB activity was estimated according to the appearance of a speciﬁc
band in EMSA. Speciﬁcity was determined in competition tests (pre-
incubation with a 100-fold molar excess of unlabeled doubled-stranded
oligonucleotides before adding the DNA probe).
Total RNA was extracted from cells (Tripure Isolation Reagent,
Boehringer Mannheim). Quantitative mRNA expression analysis was
conducted via TaqMan RT-PCR. The reverse transcriptase reaction
and further RT-PCR were performed on 1 lg RNA using TaqMan
reagents (Applied Biosystems, USA) The Taqman gene expression
probes used were: glutathione peroxidase-1 (GPx-1, Rn00577994),
UCP2 (UCPRn00571166), UCP3 (Rn00565874), superoxide dismu-
tase-2 (SOD-2, Rn00566942), and superoxide dismutase-1 (SOD1,
Rn00584772). The quantity of the transcript for a gene under study
was normalized to that of the housekeeping reference control (18S
ribosomal RNA, Hs99999901), using a comparative (2DCT) method.
Data, represented as the means ± S.E.M., were analyzed using the
Student’s t-test to determine any signiﬁcant diﬀerences. P values less
than 0.05 were considered signiﬁcant.3. Results
3.1. Gene transfer delivery of UCP3 to L6 myotubes.
Eﬀects on DWm
Fig. 1A shows that the UCP3 protein was not detectable in
diﬀerentiated L6 myotubes. This is consistent with the very low
UCP3 mRNA expression levels found in cultured myogenic
cells compared with those in skeletal muscle [33]. To obtain
UCP3 levels similar to those occurring in skeletal muscle
in vivo, a recombinant adenoviral vector containing the full-
length cDNA for the human UCP3 was employed. We ob-
served a dose-dependent increase in the presence of UCP3 in
mitochondria from myotubes treated with increasing amounts
of AdCMV-UCP3, as shown by the appearance of a single
band of approximately 34 kDa under immunoblot analysis.
Parallel assays were performed using mitochondrial fractions
from gastrocnemius muscles from rats fed a high-fat diet, a
known inducer of UCP3 gene expression in muscle. Equal
loading of mitochondrial proteins was assessed by parallel
detection of the mitochondrial protein VDAC. Our results
indicated that the induction of mitochondrial UCP3 protein
expression using an m.o.i. 200 transduction dose of
AdCMV-UCP3 fell within physiological ranges for muscles
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Fig. 1. Characterization of adenoviral-mediated UCP3 expression in L6 myotubes. A: Comparison of mitochondrial UCP3 levels in L6 myotubes
transduced with AdCMV-UCP3 at the indicated MOI and AdCMV-LacZ (MOI 200) versus the mitochondrial fraction of the skeletal muscle from
rats fed a high-fat diet (HF-D). Immunodetections of UCP3 and VDAC were carried out using 30 lg of mitochondrial protein (see Section 2). B:
Relative membrane potential (DWm) was estimated for cells transduced with either AdCMV-LacZ or AdCMV-UCP3 by the ﬂuorescence ratio 590/
527 following treatment with JC-1 (see Section 2). At top: confocal microscopy images of cells loaded with JC-1, expressing or not expressing UCP3,
or incubated with CCCP. The DWm-dependent red ﬂuorescence and DWm-independent green ﬂuorescence are shown. At bottom: results expressed as
percentages of change with respect to the control cells (AdCMV-LacZ), which was set to 100. Cells were treated under standard culture conditions.
As a positive control for DWm reduction, non-transduced cells were treated with 5 lMCCCP 40 min before determination, and the expected collapse
of DWm was observed. Bars represent the means ± S.E. of three experiments performed in triplicate. The signiﬁcance of the diﬀerences between
controls and UCP3-expressing cells is shown as *P < 0.001. The signiﬁcance of the diﬀerences between CCCP-treated and UCP3-expressing cells is
#P < 0.001.
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cytosolic or nuclear fractions of myotubes transduced with
AdCMV-UCP3 did not reveal any speciﬁc band, thus indicat-
ing the correct delivery of mitochondria to the mitochondrial
fraction (data not shown).
High UCP3 expression levels in L6 cells led to a signiﬁcant
reduction in DWm with respect to cells transduced with a con-
trol adenoviral vector driving beta-galactosidase (LacZ, con-
trol) (Fig. 1B, bottom). However, there was no collapse of
DWm, as evident from the higher levels observed with respect
to cells treated with the chemical uncoupler CCCP. Confocal
microscopy examination of cultured myotubes following treat-
ment with the DWm-sensitive compound JC-1 indicated a
homogeneous decrease in the DWm-dependent ﬂuorescence(590/527 ﬂuorescence ratio) in mitochondria from myotubes
transduced with the AdCMV-UCP3 vector (Fig. 1B, top).
3.2. Intracellular ROS generation in L6 myotubes treated with
fatty acids: eﬀects of UCP3
Dose-response analysis of the eﬀects exerted by two fatty
acid types, palmitate and oleate, on ROS production is shown
in Fig. 2A. Oleate had a low but signiﬁcant eﬀect on ROS
production, with a maximum induction of approximately
20% with respect to control cells (BSA-treated) attained at
0.1 mM. No eﬀect was observed at lower concentrations.
Palmitate exerted much greater eﬀects on ROS production,
with a maximum induction of 80% respect to BSA at
0.5 mM. The ROS induction levels generated by palmitate
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Fig. 2. Intracellular ROS generation in L6 myotubes treated with fatty
acids; eﬀects of UCP3 expression. A: Dose-dependent eﬀects of BSA-
conjugated palmitate or oleate during 24 h on intracellular ROS
generation in L6 myotubes. ROS generation is measured as explained
in Section 2. Data are expressed as a arbitray ﬂuorescence units per mg
protein (see Methods section). Results represent the means ± S.E.M. of
at least 3 separate experiments. Statistical signiﬁcance of diﬀerences
between fatty acid-treated and controls are shown as *P < 0, 05 and
those between palmitate-treated and oleate-treated cells as #P < 0.05.
B: Eﬀects of UCP3 expression on palmitate-induced intracellular ROS
generation in L6 myotubes. L6 myotubes previously transduced with
AdCMV-LacZ or AdCMV-UCP3 were exposed to 1 mM BSA-
conjugated palmitate for 24 h. Data are expressed as a percentage of
the control AdCMV-LacZ treated with BSA. Results represent the
means ± S.E.M. of at least 3 separate experiments. Statistical signif-
icance of diﬀerences between palmitate-treated and control BSAs are
shown as *P < 0.05 and those due to UCP3 as #P < 0.05.
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Fig. 3. Eﬀects of fatty acid treatments on NF-jB binding activity of
L6 myotubes. Nuclear extracts from L6 myotubes treated with
diﬀerent concentrations of BSA-conjugated oleate or palmitate (see
Section 2) for 24 h were subjected to EMSA assays to determine NF-
jB binding activity. An EMSA ﬁgure representative of three indepen-
dent assays is shown.
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Fig. 4. Eﬀects of UCP3 expression on palmitate-induced NF-jB
activation in L6 myotubes. L6 myotubes were transduced or not
transduced with AdCMV-LacZ or AdCMV-UCP3, and then subse-
quently treated for 24 h with 1 mM BSA-conjugated palmitate (see
Section 2). Nuclear extracts from these cells were subjected to EMSA
assay to determine NF-jB binding activity. Top, An EMSA ﬁgure
representative is shown. Bottom, bars are means ± S.E.M. of densi-
tometric scanning of the NF-jB-binding band from three independent
assays.
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oleate except at the low dose of 0.1 mM fatty acid.
The addition of 40 lM etomoxir 1 h before the treatment
with fatty acids increased ROS production induced by 1 mM
palmitate (2.3 + 0.1 fold induction respect 1 mM palmitate-
treated, non etomoxir-treated, myotubes; P < 0.05).
Basal ROS levels in myotubes expressing high UCP3 levels
were not signiﬁcantly diﬀerent from cells treated with equiva-
lent amounts of a control adenoviral vector (Fig. 2B). When
these cells were treated with palmitate, the ROS induction
proved higher in myotubes expressing UCP3.
Myotubes expressing UCP3 showed enhanced oxidation of
palmitate (1.61 ± 0.08-fold induction respect to controls,
P < 0.05), in agreement with previous observations in other
myogenic cells [13,14].
Although high concentrations of palmitate are known to
trigger apoptosis in several cell types, including myogenic cells[34,35] we did not observe either caspase-3 induction or cas-
pase-9 activity following exposure of cells to any of the palm-
itate concentrations tested (0.1 mM; 0.5 mM; 1 mM), neither
in the absence or presence of UCP3.
3.3. Eﬀects of fatty acids on NF-jB activity in L6 myotubes:
eﬀects of UCP3
L6 myotubes were treated with increasing amounts of oleate
or palmitate, with NF-jB activation determined through an
electrophoretic mobility shift assay. Results indicated that ole-
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Fig. 5. Eﬀects of palmitate and UCP3 expression on oxidative stress-
related gene expression in L6 myotubes. L6 myotubes previously
transduced with AdCMV-LacZ or AdCMV-UCP3 were exposed to
1 mM BSA-conjugated palmitate (Palm) for 24 h. Quantitative mRNA
expression analysis was carried out using a two-step real-time PCR
reaction (see Section 2). Statistical signiﬁcance of diﬀerences between
palmitate-treated and control BSA in the absence or presence of UCP3
are shown as *P < 0.05, and the statistical signiﬁcance of UCP3 eﬀects
in the absence or presence of palmitate are shown as #P < 0.05.
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the speciﬁc NF-jB band, while palmitate led to a much more
robust eﬀect, with a maximal induction of approximately 2-
fold with respect to controls at 1 mM (Fig. 3). Fig. 4 shows
the eﬀects of palmitate on L6 myotubes that had been induced
to express high levels of UCP3 in mitochondria. UCP3 expres-
sion did not cause any signiﬁcant eﬀects on NF-jB activity
compared with untreated L6 myotubes or those transduced
with the control adenoviral vector. The addition of palmitate
elicited a signiﬁcant induction of NF-jB activity in L6 myotu-
bes that proved higher in cells exhibiting high UCP3 expres-
sion.
3.4. Gene expression in L6 myotubes in response to palmitate:
eﬀects of UCP3
We analyzed the eﬀects of palmitate on the expression of
ROS-related genes in L6 myotubes, treated with either the con-
trol adenoviral vector or transduced with the vector leading to
high UCP3 protein levels (Fig. 5). Palmitate treatment did not
signiﬁcantly modify mRNA levels for SOD1, SOD2 and GPx1
in control cells, but did lead to an increase in UCP2 mRNA.
The high UCP3 expression achieved with the adenoviral vector
caused a reduction in UCP2 mRNA, both in basal and palm-
itate-treated myotubes, without altering SOD1, SOD2, and
GPx1 mRNA, either in basal conditions or in response to
palmitate.4. Discussion
Current conceptions regarding the biochemical behavior of
UCP3 in isolated mitochondria suggest that the reduction in
mitochondrial membrane potential elicited by its proton con-
ductance activity, especially in the presence of fatty acids,
may protect against ROS. However, our results indicate that
in cultured skeletal muscle cells, high UCP3 levels failed toreduce ROS levels in myotubes, either in basal conditions or
in response to palmitate. These ﬁndings are in agreement with
recent observations indicating that UCP3 does not protect
against ROS production in response to the apoptotic agent
staurosporine [36].
The exposure of diﬀerentiated muscle cells to fatty acids
results in an increase in intracellular ROS, much more pro-
nounced for palmitate than for oleate. This was observed both
directly using a ROS-sensitive ﬂuorescent probe, as well as
indirectly via the analysis of NF-jB activation, a sensor of
ROS-mediated cell stress. The induction of ROS production
and NF-jB in skeletal muscle myotubes in response to fatty
acids proved similar to that observed in cardiomyocytes [27]
or pancreatic beta-cells [29], but contrasted with studies on
other cell systems, such as endothelial cells, in which fatty acids
reduce ROS [30]. The rise in ROS in response to fatty acids is
consistent with the enhancement of mitochondrial oxidative
pathways when fatty acids act as fuel substrates. In other cell
systems, the highest eﬀects of palmitate have been attributed
to the activation of ceramide synthesis pathways, as well as
to the activation of non-mitochondrial ROS production path-
ways, such as NAD(P)H oxidase activity [37].
Transduction of skeletal muscle myotubes with an adenovi-
ral vector, thereby leading to high levels of UCP3 protein in
mitochondria (within the range of those found in muscle mito-
chondria from rats fed a high-fat diet), caused a reduction in
mitochondrial membrane potential similar to what has already
been reported in human myotubes [13], albeit much less than
the overall collapse elicited by chemical uncouplers. Under
these conditions, the presence of high UCP3 levels did not re-
duce, but in fact even somewhat enhanced ROS production
when the myotubes were exposed to fatty acids. The absence
of any protective eﬀects, as well as the rather increased ROS
production in response to palmitate, was also apparent by
the extent of the activation of the oxidative stress-sensitive
transcription factor NF-jB. This is a distinct event with re-
spect to ROS production itself, but it is indicative of the oxida-
tive stress experienced by cells. These ﬁndings were surprising
and limitations inherent to the features of the present study,
such as the use of a whole cell (diﬀerentiated myotubes) system
model in contrast with isolated mitochondria, or the possibility
of incorrect folding of recombinant UCP3 cannot be abso-
lutely ruled out to account for the observed eﬀects. However,
the absence of any eﬀect caused by UCP3 expression on basal
levels of ROS or on sensors of oxidative stress (NF-jB activa-
tion or expression of oxidative-stress related genes such as
GPx-1, SOD1 and SOD2) makes unlikely a major non-speciﬁc
stressful action of recombinant UCP3 on myogenic cells. The
speciﬁc eﬀect observed for UCP3 only in response to palmitate
is reminiscent of previous studies on other cell systems that had
already noted an association between lowered mitochondrial
membrane potential and enhanced ROS production in the
presence of palmitate [29].
A ﬁrst hypothesis to explain the eﬀects of UCP3 in the pres-
ence of palmitate would be related to the enhancement in
palmitate oxidation when muscle cells express high levels of
UCP3 [13,14 and present results]. This could lead to enhanced
ROS production and the potential eﬀects that UCP3-driven
mild uncoupling might have in reducing ROS production
may be oﬀset by the enhanced oxidative activity of fatty acids
in mitochondria and the subsequently increased ROS produc-
tion. However, other mechanisms underlying the action of
960 C. Duval et al. / FEBS Letters 581 (2007) 955–961UCP3 must also be considered. Enhanced ROS production
when palmitate oxidation is blocked by etomoxir suggests that
the palmitate oxidation itself does not lead to greater ROS
production; quite the opposite, high concentrations of palmi-
tate inside the cells, which can be generated by impaired oxida-
tion, promote pathways of ROS production not linked to
palmitate oxidation itself. Among these, ceramide production
is one previously recognized mechanism. Ceramide can report-
edly inhibit respiratory complex III and, similar to such phar-
macological agents as antimycin A, favor ROS production in
this way [38,39]. The combination of complex III inhibition
and chemical uncoupling is also known to potentially lead to
maximal ROS production [40], thereby explaining perhaps
the enhanced ROS production by UCP3 in the presence of
palmitate. Experimental research is under way to conﬁrm or
refute this possibility.
Another mechanism by which UCP3 activity may enhance
ROS production is indirectly via its eﬀects on UCP2 gene
expression in response to fatty acids. We reported previously
that the induction of UCP3 expression in muscle cells causes
a reduction in UCP2 mRNA levels in basal conditions [36].
In the present study we observed that UCP2 gene expression
is up-regulated in response to palmitate in myotubes, consis-
tent with previous reports indicating that fatty acids activate
the UCP2 gene promoter [41,42]. Moreover, the up-regulation
of UCP2 gene expression in response to palmitate is lowered
by the presence of high levels of UCP3. Again, this eﬀect can
be related to the enhancement of palmitate oxidation due to
the presence of UCP3, since this would result in the increased
removal of fatty acids as activators of UCP2 gene transcription
via their oxidation. UCP3 and UCP2 are similar proteins, and
the latter has also been proposed to be a protective agent
against ROS production [20,21]. If UCP2 was, in fact, more
eﬀective than UCP3 in reducing ROS production, the down-
regulation observed could contribute to the increase in ROS
levels elicited by UCP3 in response to palmitate, at least in cul-
tured muscle cells. In summary, we show that, at the cellular
level, fatty acids promote ROS production in diﬀerentiated
muscle cells. However, UCP3, despite being capable of lower-
ing mitochondrial membrane potential, does not protect
against ROS production in response to palmitate, in the con-
text of diﬀerentiated muscle cells.
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